The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Chronic Obstructive Pulmonary Disease in Patients Undergoing Transcatheter Aortic Valve Implantation
Open accessAbstract
Objectives This study sought to determine the effects of chronic obstructive pulmonary disease (COPD) on clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI) and to determine the factors associated with worse outcomes in COPD patients.Background No data exist on the factors determining poorer outcomes in COPD patients undergoing TAVI.Methods A total of 319 consecutive patients (29.5% with COPD) who underwent TAVI were studied. Functional status was evaluated by New York Heart Association (NYHA) functional class, Duke Activity Status Index, and the 6-min walk test (6MWT) at baseline and at 6 to 12 months. The TAVI treatment was considered futile if the patient either died or did not improve in NYHA functional class at 6-month follow-up.Results Survival rates at 1 year were 70.6% in COPD patients and 84.5% in patients without COPD (p = 0.008). COPD was an independent predictor of cumulative mortality after TAVI (hazard ratio: 1.84; 95% confidence interval: 1.08 to 3.13; p = 0.026). Improvement in functional status was observed after TAVI (p < 0.001 for NYHA functional class, Duke Activity Status Index, and 6MWT), but COPD patients exhibited less (p = 0.036) improvement in NYHA functional class. Among COPD patients, a shorter 6MWT distance predicted cumulative mortality (p = 0.013), whereas poorer baseline spirometry results (FEV1 [forced expiratory volume in the first second of expiration]) determined a higher rate of periprocedural pulmonary complications (p = 0.040). The TAVI treatment was futile in 40 COPD patients (42.5%) and a baseline 6MWT distance <170 m best determined the lack of benefit after TAVI (p = 0.002).Conclusions COPD was associated with a higher rate of mortality at mid-term follow-up. Among COPD patients, a higher degree of airway obstruction and a lower exercise capacity determined a higher risk of pulmonary complications and mortality, respectively. TAVI was futile in more than one-third of the COPD patients, and a shorter distance walked at the 6MWT predicted the lack of benefit after TAVI. These results may help to improve the clinical decision-making process in this challenging group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Results from some recent studies suggest that TAVR might be preferable to surgical AVR in patients with diabetes, chronic obstructive pulmonary disease, pulmonary hypertension, small aortic annulus and low-flow, low-gradient AS262–266.”
From Calcific aortic stenosis (2016) · cites this paper as [265]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008232 · Cited by 7,205
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103510 · Cited by 6,345
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Hlatky, M. A., Boineau, R., Higginbotham, M. B., Lee, K. L., Mark, D. B., Califf, R. M., Cobb, F. R., & Pryor, D. B. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90496-7 · Cited by 1,747
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
Gilard, M., Eltchaninoff, H., Iung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., Leprince, P., Leguerrier, A., Lievre, M., Prat, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114705 · Cited by 1,228
Tamburino, C., Capodanno, D., Ramondo, A. B., Petronio, A. S., Ettori, F., Santoro, G., Klugmann, S., Bedogni, F., Maisano, F., Marzocchi, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.946533 · Cited by 1,123
Smetana, G. W., Lawrence, V. A., & Cornell, J. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-8-200604180-00009 · Cited by 1,040
Brown, J. M., O'Brien, S. M., Wu, C., Sikora, J. A. H., Griffith, B. P., & Gammie, J. S. (2009) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.08.015 · Cited by 937
Bittner, V. (1993) · JAMA · doi:10.1001/jama.270.14.1702 · Cited by 934
Cited by
Sorted by citations
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Iung, B., Laouenan, C., Himbert, D., Eltchaninoff, H., Chevreul, K., Donzeau‐Gouge, P., Fajadet, J. C., Leprince, P. N., Leguerrier, A., Lièvre, M. M., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305314 · Cited by 230
Kim, D. H., Kim, C. A., Placide, S., Lipsitz, L. A., & Marcantonio, E. R. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0652 · Cited by 225
Puri, R., Iung, B., Cohen, D. J., & Rodés‐Cabau, J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv756 · Cited by 222
Self-citationBavaria, J. E., Tommaso, C. L., Brindis, R. G., Carroll, J. D., Deeb, G. M., Feldman, T. E., Gleason, T. G., Horlick, E. M., Kavinsky, C. J., Kumbhani, D. J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.002 · Cited by 162
Metadata
- Authors
- Mok, M., Nombela-Franco, L., Dumont, E., Urena, M., DeLarochellière, R., Doyle, D., Villeneuve, J., Côté, M., Ribeiro, H. B., Allende, R., Laflamme, J., DeLarochellière, H., Laflamme, L., Amat-Santos, I., Pibarot, P., Maltais, F., & Rodés-Cabau, J.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- ORCID
- Venue
- JACC: Cardiovascular Interventions
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 6
- Issue
- 10
- Pages
- 1072-1084
- ISSN
- 1876-7605 (ISSN-L)
- 1936-8798
- OpenAlex
- W204202587
- Cited by
- 110
- References
- 34
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 7 · 2021: 8 · 2020: 11 · 2019: 8 · 2018: 7 · 2017: 14 · 2016: 10 · 2015: 11 · 2014: 4
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- JACC: Cardiovascular Interventions (publishedVersion)
- PubMed (publishedVersion)
- Corpus Université Laval (Université Laval) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- Fundación Mutua Madrileña
- Edwards Lifesciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- chronic obstructive pulmonary disease, transcatheter aortic valve implantation, mortality, functional status, 6-minute walk test, exercise capacity, pulmonary complications, procedural complications, spirometry, FEV1, NYHA functional class, futility of treatment, aortic stenosis, risk factors for poor outcome, airway obstruction, Duke Activity Status Index
- MeSH terms
- Aged, Aged, 80 and over, Aortic Valve Stenosis, Exercise Test, Female, Cardiac Catheterization, Humans, Lung, Male, Predictive Value of Tests, Risk Factors, Severity of Illness Index, Spirometry, Time Factors, Walking, Treatment Outcome, Exercise Tolerance, Patient Selection, Heart Valve Prosthesis Implantation, Recovery of Function, Pulmonary Disease, Chronic Obstructive, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
